| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |